NTX-301 in MDS/AML
NCT04167917
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Chronic Myelomonocytic Leukemia
Interventions
DRUG:
NTX-301
Sponsor
University of Alabama at Birmingham